Not exact matches
The study published in the journal Schizophrenia Bulletin reports preliminary results showing that a blood test, when used in psychiatric patients experiencing
symptoms that are considered to be indicators
of a high risk for
psychosis, identifies those who later went
on to develop
psychosis.
Only about a third
of people with such
symptoms do go
on to develop
psychosis, however, and antipsychotic drugs can cause nasty side effects, so these are rarely given as a preventative.
He's consulting with Boehringer Ingelheim, a pharmaceutical company headquartered in Germany, where scientists this fall began offering an experimental drug to people at very high risk
of psychosis who are eligible based
on the severity
of their
symptoms.
«In general, lupus patients commonly have a broad range
of neuropsychiatric
symptoms, including anxiety, depression, headaches, seizures, even
psychosis,» says Allison Bialas, PhD, first author
on the study and a research fellow working in the lab
of Michael Carroll, PhD, senior author
on the study, who are part
of the Boston Children's Program in Cellular and Molecular Medicine.
If confirmed, the link between neural noise and
psychosis could shed light
on the biology
of some
of the
symptoms associated with schizophrenia.
Patients can find themselves
on a whole pharmacopoeia
of drugs that address their NMS
on a one - off basis, targeting individual
symptoms — sildenafil (Viagra ®) for erectile dysfunction, stimulants for daytime sleepiness and fatigue, clozapine for
psychosis, and even glycopyrrolate for frank, uncontrolled drooling — but again, these drugs do nothing to check the underlying progression
of AS pathology, and the NMS continue to worsen over time.
Psychosis is a term used to indicate mental health disorders that present with
symptoms like hallucinations (such as hearing voices) or delusions (unshakeable beliefs based
on the person's altered perception
of reality, which may not correspond to the way others see the world).
The treatment appeared to have stronger effects
on cognitive versus emotional aspects
of symptoms, suggesting that perhaps the treatment protocol should be revised to improve its impact
on emotional aspects
of psychosis.
301 people aged 18 — 65 years (218 without carers, 83 with carers) with non-affective
psychosis (ICD - 10 category F2 and DSM - IV) and a second or subsequent psychotic episode not more than 3 months before the trial began, plus a rating
of at least 4 for one or more positive
symptoms on the Positive and Negative Syndrome Scale (PANSS).
What is the effect
of cognitive behavioural therapy (CBT) and family intervention
on relapse rates and
symptoms in people with recently relapsed non-affective
psychosis?
There are conflicting findings about the extent to which certain specific
symptoms, notably some kinds
of psychosis (hallucinations or delusions) that can occur in disorders such as schizophrenia, delusional disorder or mood disorder, are linked to an increased risk
of serious violence
on average.
A trial
of CT in acute
psychosis conducted by the authors has shown a significant impact
on the rate and degree
of recovery
of positive
symptoms, the focus
of the intervention.